ArticleBioengineering (Basel, Switzerland)2026
Dual-Stream Fusion of Eye-Tracking and ECG Signals for Fatigue Detection in Remote Tower Air Traffic Controllers.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Fatigue detection in remote tower air traffic controllers is important for maintaining operational safety under sustained visual monitoring and high cognitive workload. This study proposes MFD-Net, a dual-stream multimodal fusion framework using eye-tracking and electrocardiogram (ECG) signals. The model separately encodes eye-tracking and ECG-derived temporal inputs, incorporates an ECG-derived RMSSD expert feature, and performs lightweight late fusion for fatigue-state classification. Under the mixed-subject random-window protocol, MFD-Net achieved an Accuracy of 85.20%, a Recall of 83.33%, and an AUC of 0.9337. Because overlapping windows from the same participant and scenario could appear in both training and test sets, this result should be interpreted as a potentially optimistic within-distribution estimate. Under the stricter zero-shot leave-one-subject-out (LOSO) protocol, performance decreased substantially, with an Accuracy of 70.95±21.59%, a Recall of 22.98±36.30%, and an AUC of 0.6025±0.2984. This low zero-shot Recall indicates limited subject-independent fatigue-detection capability. Lightweight target-subject calibration and sequential probability aggregation improved adaptation and temporal stability, although the calibration results should be interpreted cautiously because random target-subject windows were used for fine-tuning. These findings suggest that eye-tracking and ECG fusion are promising under controlled conditions, while practical deployment requires deployment-oriented calibration protocols, recall-oriented optimization, and further real-world validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.